RxDoctor Payments Data

Brian Johnson, MD

Family Medicine · Wichita, KSNPI 1306803911

Payments from drug & device makers

$455in general payments, 2019–2025

Across 33 payments — averaging $13.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$79
  • Novo Nordisk$69
  • Johnson & Johnson$59
  • Amgen$56
  • Sanofi Pasteur Inc.$43
  • Merck$36
  • plus $113 from 8 others

What the payments were for

  • Food & beverage$41391%
  • Education$429%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$455 in reported general payments places this provider in the 45th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$212,362
Medicare patients
448
Services billed
4,205

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban114$93,470
JardianceEmpagliflozin79$69,568
OzempicSemaglutide61$67,436
FarxigaDapagliflozin Propanediol77$60,826
Trelegy ElliptaFluticasone/Umeclidin/Vilanter60$55,935
XareltoRivaroxaban55$45,889
JanuviaSitagliptin Phosphate44$31,228
MounjaroTirzepatide18$25,590
Tresiba Flextouch U-100Insulin Degludec37$18,883
Soliqua 100-33Insulin Glargine/Lixisenatide14$14,148
TradjentaLinagliptin22$10,017
Tresiba Flextouch U-200Insulin Degludec16$9,309
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog13$7,996
Spiriva HandihalerTiotropium Bromide12$7,988
Breo ElliptaFluticasone/Vilanterol15$6,948

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$13$93,470114 claims
Boehringer IngelheimJardiance, Tradjenta$79$79,585101 claims
Novo NordiskOzempic$69$67,43661 claims
AstraZenecaFarxiga$11$60,82677 claims
Johnson & JohnsonXarelto$59$45,88955 claims
MerckJanuvia, Janumet Xr$36$36,96156 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$13$14,14814 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Wichita

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →